IQVIA Reports Second-Quarter 2026 Results

{
  "signal_id": "18e8bc05-72c4-b502-6d48-7c07b2b8f0d1",
  "signal_type": "news",
  "signal_subtype": "has_earnings",
  "detected_at": "2026-07-29T01:44:01+00:00",
  "company": {
    "name": "IQVIA",
    "domain": "iqvia.com"
  },
  "data": {
    "url": "https://www.biospace.com/press-releases/iqvia-reports-second-quarter-2026-results",
    "title": "IQVIA Reports Second-Quarter 2026 Results - BioSpace",
    "excerpt": "RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended June 30, 2026. Year-Over-Year Comparisons As previously disclosed, effective January 1, 2026, the company implemented a new, simplified organizational model to strengthen collaboration, enhance efficiency, and support continued growth. As a result, the company reports its results within two segments: Commercial Solutions and Research & Development Solutions (R&DS). In conjunction with this change, prior period segment amounts have been recast to conform to this reporting structure. Second-Quarter 2026 Operating Results \"In a strengthening market environment, the IQVIA team executed well and delivered outstanding results, exceeding the high-end of our expectations for revenue, Adjusted EBITDA and Adjusted Diluted EPS,\" said Ari Bousbib, chairman and CEO of IQVIA. \"R&D Solutions generated record-level net new bookings of over $3.1 billion and reported 7% organic revenue growth. In Commercial Solutions, double digit growth in patient solutions and commercial engagement services, high-single-digit organic growth in analytics and consulting, and increased adoption of our AI solutions all...",
    "summary": "IQVIA reported a GAAP Net Income of $530 million for the first six months of 2026.",
    "location": "Research Triangle Park, NC, USA",
    "planning": false,
    "image_url": "https://static.biospace.com/dims4/default/d32393a/2147483647/strip/true/crop/1120x630+40+0/resize/1440x810!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fcc%2F88%2Fa9fddaf440db946b77e1d45d2e26%2Fbiospace-5.png",
    "confidence": 0.9,
    "published_at": "2026-07-29T01:44:01Z",
    "location_data": [
      {
        "city": "Research Triangle Park",
        "state": "North Carolina",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-06-30",
    "article_sentence": "GAAP Net Income was $530 million and GAAP Diluted Earnings per Share was $3.14.",
    "amount_normalized": 530000000
  }
}

curl https://signals.autobound.ai/v1/signals/18e8bc05-72c4-b502-6d48-7c07b2b8f0d1 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"iqvia.com","limit":20}'